Solutions

The Science-First Full Service CRO and Consultancy for Immunology and Inflammation

Driving Successful Outcomes for Autoimmune/Immunology Clinical Trials 

Patients with autoimmune/immune diseases often struggle with chronic conditions that impact daily life. Driving speed, efficiency, and agility in clinical trials is necessary to get new therapies to patients faster. At Veristat, we have assisted sponsors at the forefront of clinical development for autoimmune/immune diseases, supporting more than 70 clinical trials and consulting projects in the last five years. Over 40% of these therapies are for rare autoimmune diseases or disorders. Trust Veristat to deliver excellence in scientific thinking and the ideal regulatory path and study design to propel your trial forward. 

Looking to accelerate your immunology clinical trial?  Let's Talk. 

AutoImmune/Immunology Experience in the Past 5 Years 

+0

Clinical trials & consulting projects

0%

In Biologic Therapeutics

0%

For Rare/Ultra-Rare Indications

0%

of global team members have immunology experience

Advance Your Immunology & Inflammation Therapy to Approval and Beyond

Planning early and comprehensively is crucial to achieve approval success. As a full-service CRO with a therapeutic focus in immunology, Veristat integrates deep therapeutic expertise and actionable insights to guide your decision-making, mitigate risks, and prove safety and efficacy so you can reach your next development milestone.  

Our bold-thinking experts are prepared to launch your Autoimmune/Immunology trial: 

  1. Rapidly advance your clinical trial to its next milestone
  2. Reliably achieve regulatory success with regulatory consulting advice, marketing application preparation support, and regulatory submissions/publishing.    
  3. Gain trusted strategic advice from scientific experts across all disciplines along the clinical development and commercialization pathway.  
  4. Ensure ongoing risk management and patient safety for marked products with Post-Market Pharmacovigilance. 
“We thank the entire Veristat team who worked diligently to help us bring our critical therapy to patients with no other FDA-approved treatment options,”
Chief Medical Officer
Biotechnology Company

Deep and Broad Experience in Immunology & Inflammation Therapy Development  

Rare Indications

  • ADA -SCID 
  • Behcet’s Disease 
  • Dermatomyositis 
  • Lupus 
  • Systemic Mastocytosis 
  • And more… 
therapeutic_Endocrine_image4

Non-Rare Indications 

  • Celiac Disease 
  • Crohn’s Disease 
  • Gout 
  • Psoriasis 
  • Rheumatoid Arthritis 
  • And more… 
therapeutic_image5

Find out how our clinical trial and regulatory experts can help with your next study or program.

LET'S TALK

Learn More with These Resources

Newsletter

Recognize Rare Disease Month with Veristat

Case Study

Strategic Clinical Development Consulting

Fact Sheet

Adaptive Design Fact Sheet